According to HealthEquity's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.98105. At the end of 2022 the company had a P/S ratio of 7.92.
Year | P/S ratio | Change |
---|---|---|
2022 | 7.92 | 6.29% |
2021 | 7.45 | 40.62% |
2020 | 5.30 | -46.42% |
2019 | 9.89 | -53.02% |
2018 | 21.1 | 49.28% |
2017 | 14.1 | 19.87% |
2016 | 11.8 | -27.2% |
2015 | 16.2 | 16% |
2014 | 13.9 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
![]() FirstCash FCFS | 1.60 | -73.19% | ๐บ๐ธ USA |
![]() Amerco UHAL | 1.79 | -70.13% | ๐บ๐ธ USA |
![]() Green Dot GDOT | 0.5875 | -90.18% | ๐บ๐ธ USA |